Cytokine Regulation in Neurodegenerative Diseases

Neurodegenerative diseases are increasingly recognised as disorders in which the delicate equilibrium between pro-inflammatory and anti-inflammatory cytokines dictates the trajectory of neuronal survival and network integrity. Cytokine regulation encompasses the production, signalling and resolution phases of the immune response in the central nervous system, engaging resident microglia, astrocytes and infiltrating lymphocytes. Dysregulated cytokine profiles fuel chronic neuroinflammation, exacerbate protein aggregation and disrupt synaptic plasticity, thereby accelerating neurodegeneration in disorders such as Alzheimer’s, Parkinson’s and amyotrophic lateral sclerosis. Key modulators include Transforming Growth Factor-β (TGF-β), which exerts neuroprotective and immunosuppressive actions through Smad-dependent pathways, and Interleukin-10 (IL-10), the principal anti-inflammatory cytokine that limits microglial cytotoxicity and promotes tissue repair. Aberrant shifts towards a pro-inflammatory microglial phenotype (often termed M1) coincide with increased production of cytokines such as tumour necrosis factor-α and interleukin-1β, whereas a restorative (M2-like) state fosters release of IL-10 and TGF-β. Understanding how these mediators influence synaptic strength, phagocytic clearance of pathological proteins and blood–brain barrier integrity is essential for the development of targeted immunotherapies and for interpreting the global impact of lifestyle and genetic factors on disease progression.

Research from Nature Portfolio

Recent studies have demonstrated that TGF-β1 is central to the mechanisms underlying synaptic plasticity and memory consolidation in adult hippocampus. In experimental models, administration of exogenous TGF-β1 converted early-phase long-term potentiation (LTP) into its late-phase form, indicating a direct role in sustaining synaptic efficacy. Conversely, pharmacological inhibition of endogenous TGF-β1 signalling impaired both LTP induction and object recognition memory, effects which were rescued by subsequent TGF-β1 delivery. These findings establish that homeostatic cytokine signalling is not merely a bystander but a requisite component of the molecular orchestra that underpins learning and memory, offering a paradigm for cytokine-based modulation of cognitive decline in neurodegenerative settings.

Cytokine Regulation in Neurodegenerative Diseases publication trend

The graph below shows the total number of articles in cytokine regulation in neurodegenerative diseases across all publications each year (not limited to Nature Index journals).

Technical terms

Cytokine: A small secreted protein that mediates and regulates immunity, inflammation and haematopoiesis.

Microglia: Resident immune cells of the central nervous system that survey the brain microenvironment and orchestrate inflammatory responses.

Neuroinflammation: The inflammatory response within the brain or spinal cord, involving glial activation and cytokine release.

Transforming Growth Factor-β (TGF-β): A multifunctional cytokine that regulates cell growth, differentiation and immune responses, signalling primarily via Smad proteins.

Interleukin-10 (IL-10): A potent anti-inflammatory cytokine that suppresses the expression of pro-inflammatory mediators and promotes tissue repair.

Long-Term Potentiation (LTP): A long-lasting enhancement in signal transmission between neurons, considered a cellular mechanism of learning and memory.

M1/M2 Polarization: Functional states of microglia and macrophages, where M1 denotes a pro-inflammatory phenotype and M2 an anti-inflammatory, tissue-repair phenotype.

References

1. TGF-β1 signalling in Alzheimer’s pathology and cytoskeletal reorganization: a specialized Tau perspective. Journal of Neuroinflammation (2023).
2. A key role for TGF-β1 in hippocampal synaptic plasticity and memory. Scientific Reports (2015).
3. Balancing the immune response in the brain: IL-10 and its regulation. Journal of Neuroinflammation (2016).